BACKGROUND: Cirrhotic patients with Model for End-stage Liver Disease (MELD) score ≥ 40 have high risk for death without liver transplant (LT). OBJECTIVE: To evaluate these patients' outcomes after LT. METHODS: The present study analyzed a retrospective cohort of 519 cirrhotic adult patients who underwent LT at a single Canadian centre between 2002 and 2012. Primary exposure was severity of liver disease measured by MELD score at LT (≥ 40 versus < 40). Primary outcome was duration of first intensive care unit (ICU) stay after LT. Secondary outcomes were duration of first hospital stay after LT, rate of ICU readmission, re-LT and survival rates. RESULTS: On the day of LT, 5% (28 of 519) of patients had a MELD score ≥ 40. These patients had longer first ICU stays after LT (14 versus two days; P < 0.001). MELD score ≥ 40 at LT was independently associated with first ICU stay after LT ≥ 10 days (OR 3.21). These patients had longer first hospital stays after LT (45 versus 18 days; P < 0.001); however, there was no significant difference in the rate of ICU readmission (18% versus 22%; P = 0.58) or re-LT rate (4% versus 4%; P = 1.00). Cumulative survival at one month, three months, one year, three years and five years was 98%, 96%, 90%, 79% and 72%, respectively. There was no significant difference in cumulative survival stratified according to MELD score ≥ 40 versus < 40 at LT (P = 0.59). CONCLUSIONS: Cirrhotic patients with MELD score ≥ 40 at LT utilize greater postoperative health resources; however, they derive similar long-term survival benefit from LT.
BACKGROUND: Cirrhotic patients with Model for End-stage Liver Disease (MELD) score ≥ 40 have high risk for death without liver transplant (LT). OBJECTIVE: To evaluate these patients' outcomes after LT. METHODS: The present study analyzed a retrospective cohort of 519 cirrhotic adult patients who underwent LT at a single Canadian centre between 2002 and 2012. Primary exposure was severity of liver disease measured by MELD score at LT (≥ 40 versus < 40). Primary outcome was duration of first intensive care unit (ICU) stay after LT. Secondary outcomes were duration of first hospital stay after LT, rate of ICU readmission, re-LT and survival rates. RESULTS: On the day of LT, 5% (28 of 519) of patients had a MELD score ≥ 40. These patients had longer first ICU stays after LT (14 versus two days; P < 0.001). MELD score ≥ 40 at LT was independently associated with first ICU stay after LT ≥ 10 days (OR 3.21). These patients had longer first hospital stays after LT (45 versus 18 days; P < 0.001); however, there was no significant difference in the rate of ICU readmission (18% versus 22%; P = 0.58) or re-LT rate (4% versus 4%; P = 1.00). Cumulative survival at one month, three months, one year, three years and five years was 98%, 96%, 90%, 79% and 72%, respectively. There was no significant difference in cumulative survival stratified according to MELD score ≥ 40 versus < 40 at LT (P = 0.59). CONCLUSIONS: Cirrhotic patients with MELD score ≥ 40 at LT utilize greater postoperative health resources; however, they derive similar long-term survival benefit from LT.
Authors: Rolf H H Groenwold; A Rogier T Donders; Kit C B Roes; Frank E Harrell; Karel G M Moons Journal: Am J Epidemiol Date: 2011-12-23 Impact factor: 4.897
Authors: S Gupta; H Castel; R V Rao; M Picard; L Lilly; M E Faughnan; G Pomier-Layrargues Journal: Am J Transplant Date: 2009-09-22 Impact factor: 8.086
Authors: Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo Journal: Gastroenterology Date: 2013-03-06 Impact factor: 22.682
Authors: M B Majella Doyle; Erin Maynard; Yiing Lin; Neeta Vachharajani; Surendra Shenoy; Christopher Anderson; Mark Earl; Jeffrey A Lowell; William C Chapman Journal: J Am Coll Surg Date: 2013-04-30 Impact factor: 6.113
Authors: Debbie L Shawcross; Mark J Austin; Robin Daniel Abeles; Mark J W McPhail; Andrew D Yeoman; Nicholas J Taylor; Andrew J Portal; Khaleel Jamil; Georg Auzinger; Elizabeth Sizer; William Bernal; Julia A Wendon Journal: J Hepatol Date: 2012-01-13 Impact factor: 25.083
Authors: Camila Santos Pereira; Alexandra Torres de Carvalho; Adriane Dal Bosco; Luiz Alberto Forgiarini Júnior Journal: Rev Bras Ter Intensiva Date: 2019 Jan-Mar